Objective: To identify predictors of the effectiveness of hospital accreditation on process performance measures. Design: A multi-level, longitudinal, stepped-wedge, nationwide study. Participants: All patients admitted for acute stroke, heart failure, ulcers, diabetes, breast cancer and lung cancer at Danish hospitals. Intervention: The Danish Healthcare Quality Programme that was designed to create a framework for continuous quality improvement. Main outcome Measure(s): Changes in week-by-week trends of hospitals' process performance measures during the study period of 269 weeks prior to, during and post-accreditations. Process performance measures were based on 43 different processes of care obtained from national clinical quality registries. Analyses were stratified according to condition, type of care (i.e. treatment, diagnostics, secondary prevention and patient monitoring) and hospital characteristics (i.e. university affiliation, location, size, experience with accreditation and accreditation compliance). Results: A total of 1 624 518 processes of care were included. The impact of accreditation differed across the conditions. During accreditation, heart failure and breast cancer showed less improvement than other disease areas. Across all conditions, diagnostic processes improved less rapidly than other types of processes. However, after stratifying the data by hospital characteristics, process performance measures improved more uniformly. In respect of the measures that had an unsatisfactory level of quality, the processes related to diabetes, diagnostics and patient monitoring all responded to accreditation and showed an increased improvement during the preparatory work. Conclusion: Hospital characteristics were not found to be predictors for the effects of accreditation, whereas conditions and types of care to some extent predicted the effectiveness.
Introduction
Accreditation is popular among healthcare leaders globally. It is used as a tool for benchmarking quality [1] , to promote public disclosure of quality [2] and as a framework for continuous quality improvement [3] . However, accreditation usually focuses on whole organizations, making it difficult to appreciate the impact of interventions on specific outcomes. Research has provided mixed results on the overall effects of accreditation [2, [4] [5] [6] . Consequently, studies investigating the causal inferences of accreditation on clinical outcomes are needed [7] . Research on quality measures related to heart failure, pneumonia [8] acute myocardial infarction [8, 9] , cancer [10] and acute coronary syndrome [11] has shown that accreditation is associated with high-performance. However, these positive effects appear not to reflect a universal pattern, as other studies have found no or only a scattered association [12] [13] [14] . Hospital accreditation has also been a subject of investigation in the Danish context; several studies using data from national clinical registries found that compliance within a mandatory accreditation programme was associated with lower mortality and shorter lengths of stay [15, 16] . However, a lack of effect has also been observed when comparing process performance measures at hospitals participating in accreditation activities and hospitals not participating [17] In a recent study, a census of all the public, non-psychiatric hospitals in Denmark used aggregated process performance measures to examine overall changes in quality of care over time in relation to accreditation [18] . The results showed a clear improvement trend in areas in which performance had not been satisfactory during the 6-month period leading up to the on-site visit by external surveyors. However, examining aggregated measures of quality of care across a broad range of hospitals and conditions does not provide insights into how the effects of accreditation may vary across settings, patient populations and type of care. Such insights could help to identify the potential barriers affecting the effectiveness of accreditation and its downstream effects on hospital performance. Thus, this study sought to examine whether condition, type of care and hospital characteristics were predictors of the effectiveness of accreditation on hospital performance.
Methods

Context
Denmark has a population of 5.6 million people and is classified as a high-income country. The Danish health system is a publicly funded and all Danish citizens are provided with free access to healthcare. Denmark is organized into five regions that have the main responsibility for the provision of health services. These regions operate the public hospitals and have the power to organize their services according to their own preferences.
Study design and study population
A longitudinal, multi-level, stepped-wedge, nationwide study of the process performance measures related to the mandatory accreditation programme was conducted in Denmark from 1 November 2008 to 31 December 2013. Participants included all patients admitted to all Danish public, non-psychiatric hospitals during this period with at least one of the following conditions: acute stroke, heart failure, ulcers (perforated and bleeding), diabetes, breast cancer or lung cancer (see Appendix 1 for the criteria for inclusion). Six hospital mergers occurred during the study period. Thus, a total of 25 hospitals were included in the study.
Ethics approval
The Danish Data Protection Agency approved this study (J #2013-41-1742). As registry data were used informed patient consent was not required under Danish law.
The Danish healthcare quality programme
The first version of The Danish Healthcare Quality Programme (in Danish Den Danske Kvalitetsmodel (DDKM)) was launched in August 2009; the first hospital was accredited in May 2010 and the last in June 2012. The DDKM aimed to create a framework for continuous quality improvement, support transparency in quality of care and prevent errors. A team of surveyors conducted on-site surveys to judge the compliance of each hospital according to a set of standards. Their judgements were documented in reports that the independent Accreditation Award Committee then used to award levels of accreditation to hospitals. The reports identified hospitals' strengths and areas for improvement and were used by hospitals in the cycle of quality improvement. In preparation for accreditation, it was recommended that hospitals conduct an internal survey 6 months before the on-site survey.
The accreditation standard incorporates the four steps of the plando-check-act cycle to encourage systematic quality development. The DDKM comprises 104 standards that can be grouped into three categories: (i) organizational; (ii) general patient pathway and (iii) disease-specific standards. The disease-specific standards encompassed all six conditions included in this study. An example of the standard for breast cancer is shown in Appendix 1. In addition to the requirement that staff work in accordance with clinical guidelines that reflect the recommendations of national clinical guidelines, the diseasespecific standards require hospitals to report data on pre-defined processes of care for each of the six conditions. If a hospital fails to reach a pre-defined target value, the accreditation standards require the hospital to complete specific action plans to improve performance [6] . If a satisfactory level of quality is obtained, the (minimum) level must be maintained and no further action is required [19] .
Processes of care
A total of 43 different process performance measures were included from national clinical quality registries that related to the six included conditions (see Appendix 1 for a full list of the process performance measures). Data on the processes of care was prospectively collected. It is mandatory all hospitals report to the registries under Danish law. Based on recommendations from national clinical guidelines, a time limit was set for each of the individual processes to capture the timeliness of the interventions. Process performance measures were computed based on individual processes of care. A target value at the hospital level was defined, reflecting the best practice for each process performance measure. The research team classified the 43 process performance measures into four types of care: (i) treatment; (ii) diagnostics; (iii) secondary prevention and (iv) patient monitoring (see Box 1 for examples). The division was consensus- 
Hospital characteristics
The following hospital characteristics were assessed: university affiliation, the regional location of the hospital, the number of hospital beds, experience with accreditation (i.e. previous participation in accreditation programmes) [17] and accreditation level. The Accreditation Award Committee awarded accreditation level. Fully accredited hospitals require no further action; however, partially accredited hospitals are required to provide further documentation or participate in a return visit. Merged hospitals with different accreditation ratings were classified as 'partially accredited'.
Statistical analyses
To detect possible variations in the effects of accreditation, the performance data were stratified according to type of care and hospital characteristics. These stratifications were chosen because of their potential influence on the effects of accreditation [8, [20] [21] [22] . The 5-year study was divided into three periods for each hospital: (i) prior to; (ii) 'during' and (iii) 'post-accreditations'. The 'during accreditation' period was defined as a 6-month period that dated from the time at which the DDKM recommended an internal survey to the date of the on-site survey. The analyses undertaken to determine the effects of accreditation involved a comparison of trends between the three periods according to a stepped-wedge model [23] . The analyses were performed as mixed effects logistic regressions to allow adjustment for heterogeneity between hospitals [24] . Random slopes were also used at each of the three periods, allowing accreditation to have different effect on each hospital. Processes with missing data were excluded from the analyses; however, it should be noted that the proportion of missing data for the individual processes of care was generally low (<10%) and expected to be missing at random. To reflect the specific requirements of the DDKM that actions be taken when performance fails to reach a target value, the analyses were repeated using only those measures that did not reach the target value in the last 6 months prior to accreditation (see Appendix 2 for more details). Each analysis applied a two-sided significance level of 5% and was conducted in Stata 13.1 (StataCorp LP, College Station, TX). Table 2 sets out the results for all 1 624 518 processes of care after stratifying the data for conditions, type of care and hospital characteristics. Table 3 presents the corresponding results after restricting the hospital performance measures that fell beneath the target value in the last 6 months prior to the accreditation period. In total, 759 713 processes of care were included.
Results
Conditions
The main analysis showed that the effects of accreditation differed across the six conditions (see Table 2 ). In relation to heart failure (OR: 0.996 95% CI: 0.994-0.999) and breast cancer (OR: 0.991 95% CI: 0.984-0.997), the weekly improvement trends were significantly lower 'during accreditation' than prior to accreditation while the trends for the four remaining conditions remained unchanged. Compared to lung cancer (P = 0.03), ulcers (P < 0.01) and diabetes (P = 0.03), the change in improvement trends 'during the accreditation' period differed significantly for breast cancer while the change for heart failure only differed significantly compared to the change for ulcers (P = 0.01). Only heart failure (OR: 1.003 95% CI: 1.000-1.006) increased significantly in its improvement trend 'postaccreditation'. This differed significantly from the change for ulcers (P = 0.02) and diabetes (P = 0.04). When considering the process performance measures beneath target values, diabetes was the only condition that responded to accreditation. Diabetes showed a significantly positive change via an improvement trend 'during accreditation' (OR: 1.024 95% CI: 1.007-1.04); however, the trend decreased significantly 'post-accreditation' (OR: 0.974 95% CI: 0.954-0994) (see Table 3 ). The increase in the development trend 'during the accreditation' period was significantly larger than the changes for ulcers (P = 0.04), breast cancer (P < 0.01), strokes (P < 0.01) and heart failure (P < 0.01). The decreased trend for diabetes 'post-accreditation' was significantly larger than that for breast cancer (P < 0.02), strokes (P < 0.02) and heart failure (P < 0.01).
Type of care
When data were stratified according to types of care, it was found that the improvement trend for diagnostics (OR: 0.993 95% CI: 0.990-0.996) decreased more 'during accreditation' than it did prior to accreditation. This decreasing trend in diagnostics differed significantly to the change in trends for patient monitoring (P < 0.01) and patient treatment (P = 0.03). In the 'post-accreditation' phase, the trend for patient monitoring decreased significantly (OR: 0.989 95% CI: 0.980-0.998). This change in patient monitoring different significantly compared to changes in diagnostics (P < 0.01), treatment (P = 0.04) and secondary prophylaxis (P = 0.02).
An examination of the process performance measures not meeting the target values for the diagnostic performance measure showed a significant increase in the trend 'during accreditation' (OR: 1.009 95% CI: 1.004-1.014) followed by a significant decreased 'postaccreditation' (OR: 0.988 95% CI: 0.983-0.993). The performance measure for the patient monitoring processes showed a similar response to accreditation; that is, a significant increase in the trend 'during accreditation' (OR: 1.012 95% CI: 1.004-1.019) followed by a significant decrease in the trend 'post-accreditation' (OR: 0.988 95% CI: 0.979-0.996). Both diagnostics and patient monitoring developed significantly differently than secondary prophylaxis 'during accreditation' (P < 0.01, P < 0.01, respectively) and 'postaccreditation' (P < 0.01, P = 0.03, respectively).
Hospital characteristics
When the analyses were stratified according to university affiliation, geography, experience with accreditation and accreditation 
compliance (see Table 2 ), process performance measures developed in similar ways and no changes in the trend were found in relation to the accreditation cycle. A similar development occurred in three of the four groups when the data were stratified according to the number of hospital beds. However, hospitals with 301-600 hospitals beds showed an increase in the trend 'during accreditation' (OR: 1.007 95% CI: 1.0-1.013), but a decrease in trend 'post-accreditation' (OR: 0.987 95% CI: 0.980-0.990) (see Table 1 ). This development differed significantly among hospitals with more than 900 beds in both 'during the accreditation' period (P < 0.01) and 'postaccreditation' period (P < 0.01). A further analysis that included only the processes not meeting the target values showed no variances in patterns within groups when the data were stratified according to university affiliation or experience accreditation (see Table 3 ). However, variance occurred when the data were stratified according to geography, number of hospital beds and compliance with accreditation. The trends for hospitals located in the Southern Region of Denmark and the Central Region of Denmark showed significant increases in their performance of processes not meeting target values 'during accreditation' (OR: 1.008 95% CI: 1.002-1.014, OR: 1.01 95% CI: 1.005-1.016, respectively); however, this trend decreased significantly 'postaccreditation' (OR: 0.989 95% CI: 0.981-0.997, OR 0.983 95% CI: 0.974-0.992, respectively). The same development occurred in the Capital Region of Denmark ('during accreditation': OR: 1.007 95% CI: 1.000-1.015). However, the trend decreased in the 'postaccreditation' period (OR: 0.990 95% CI: 0.980-1.000) was only borderline significant. When fully and partially accredited hospitals were compared, the only difference was that the partially accredited group showed a marginally significant increase in trend 'during the Analyses stratified according to condition, type of care and hospitals characteristics. OR, odds ratio; Bold = P < 0.05 accreditation' period. Following the case in the main analysis, hospitals with 301-600 beds increased their trend significantly 'during accreditation' (OR: 1.013 95% CI: 1.004-1.022); however, this was followed by a significant decrease 'post-accreditation' (OR: 0.984 95% CI: 0.974-0.994). In the main analysis, a comparison to large hospitals (>900 beds) also revealed a difference both 'during accreditation' (P = 0.02) and 'post-accreditation' (P = 0.02). Hospitals with 601-900 beds decreased their trend 'post-accreditation' (OR: 0.989 95% CI: 0.982-0.997), but did not differ when compared with other group changes in trends.
Discussion
Broadly, differences were observed when the data were stratified according to condition and type of care; however, hospitals exhibited similar patterns regardless of their characteristics. Performance measures for heart failure, breast cancer and diagnostics differed by being negatively affected 'during accreditation'. Further, analyses restricted to the process performance measures not reaching the target values showed that processes related to diabetes and diagnostic processes drove the trend for improved performance. Across all analyses, a change in trend in any given direction was followed by a change in trend in the opposite direction in the 'post-accreditation' period. The heterogeneous findings of the accreditation effect on different types of care may be explained by organizational responses to accreditation. Such responses are likely to differ across settings, as an inherent method of freedom was incorporated in the DDKM to ensure it could work effectively in specific contexts. Given the design of this study, it was not possible to determine why the effect of accreditation was heterogeneous. However, it emphasize the importance of not only examining whether and where accreditation works, but also why and how it works.
The analysis of type of care showed that the category 'patient monitoring' responded to accreditation. However, this finding must be Includes processes where the target value was not met in the 6 months prior to the during accreditation period for the individual hospitals. Analyses stratified according to condition, type of care and hospitals characteristics. Bold = P < 0.05.
interpreted with caution, as it was primarily explained by the improvement in processes of care related to diabetes. This was a combination of the large volume of patients with diabetes and that all the processes of care related to diabetes were categorized as 'patient monitoring' (see Table 1 ). Thus, it was difficult to disentangle the role of diabetes itself from the potential role of the processes of care related to patient monitoring. Previous research has shown that the benefits of accreditation are linked with hospital size; nurses perceived higher levels of improvement in quality in small-and medium-sized hospitals compared to large-sized hospitals [20] . A homogeneous culture and reduced bureaucracy have been linked to smaller organizations being more easily able to implement quality improvement initiatives [25] . This supports the contention that smaller organizations can more readily achieve positive results with accreditation. However, this link was not supported by the results of this study where the effect only varied slightly between the different sized hospitals. This study showed a clear pattern whereby a positive change was followed by a negative change and vice versa. These results accorded with those of a previous study by Devkaran and O'Farrell [26] that used a time-series design based on 23 quality measures at a single hospital in Abu Dhabi to examine the effect of accreditation over a 4-year period (1-year pre-accreditation and 3-year post-accreditation). Devkaran and O'Farrell [26] showed a significant negative change in slope after accreditation for the composite score and for 11 of the individual quality measures. These results together with the results of the present study suggest that accreditation acts as a stimulus for hospitals to reprioritise their focus and resources in the preparation period, but that they return to normal operational performance post-accreditation.
One of the present study's strengths was its nationwide and systematic prospective collection of data that limited the risk of selection and information bias. The use of a segmented longitudinal analysis coupled with a naturally occurring stepped-wedge effect reduced the risk that the observed trends would be attributed to interventions other than accreditation and thus provided a strong design for detecting changes over time.
One limitation of the study was the division of time periods. The divisions were based on the DDKM recommendations, as an exact start date for implementation was not available. Inaccurate divisions would most likely have led to non-differential misclassifications and findings that were more conservative. We also cannot rule out the risk of gaming (i.e. the reporting of false process performance data). However, there were no financial incentives for reporting false data and structured audit processes were regularly undertaken by the clinical quality databases on a national, regional and local basis to critically assess the quality of the data set [27] .
Conclusion
We found that accreditation affected quality improvement differently across conditions and types of care, but affected all types of hospitals to a similar extent. Processes related to heart failure, breast cancer and diagnostics appeared to be negatively affected by accreditation. Conversely, diabetes and diagnostics with an unsatisfactory level of quality were positively affected by accreditation.
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